Plunkett Research Online: Eiger BioPharmaceuticals

EIGER BIOPHARMACEUTICALS (EIGR) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eiger BioPharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with rit.....


EIGER BIOPHARMACEUTICALS

Ticker: EIGR
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 272-6138
Fax: 650 618-1621
Address: 350 Cambridge Avenue
Palo Alto, CA 94306 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

David ApelianCEO/Director/President
William KachioffCFO/Chief Accounting Officer
See More
Eiger BioPharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of drugs for serious, rare, and ultra-rare diseases with high unmet medical needs and no approved therapies. Its program lonafarnib, a prenylation inhibitor, boosted with rit.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture